Speciality: Oncology
Description:
Welcome to an insightful panel discussion on the role of palbociclib in treating endocrine-resistant breast cancer. Leading oncologists Dr. Srinivas K G, Dr. Abhaya Kumar S M, and Dr. Vishwanath S, delve into the complexities of hormone receptor-positive, HER2-negative breast cancer, analyzing the results of the clinical trial and exploring optimal treatment strategies in the face of endocrine resistance. The panel offers a comprehensive overview of the trial, including patient selection criteria, primary endpoints, and a detailed analysis of the outcomes.
This video provides a critical analysis of the trial's findings, exploring potential reasons for the observed results and discussing the implications for clinical practice. The experts debate the optimal duration of palbociclib treatment and its role in managing patients with hormone receptor-positive breast cancer. They also address the challenges in pathways development for advanced breast cancer.
Gain valuable insights from these leading experts to enhance your understanding of endocrine-resistant breast cancer and the role of palbociclib. Don't miss this opportunity to expand your knowledge and improve patient care. Be sure to watch the entire video and subscribe for more expert-led discussions on cutting-edge oncology topics.
See More Webinars @ Hidoc Webinars
1.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
2.
Why breast cancer survivors don't take their medicine, and what can be done about it.
3.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
4.
C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.
5.
Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.
1.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
2.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
3.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
4.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
5.
What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation